Schizophrenia News

Regular marijuana use significantly increased risk for subclinical psychotic symptoms, particularly paranoia and hallucinations, among adolescent males.

Recent findings indicated individuals who used antipsychotics had a higher risk for myocardial infarction compared with those who did not use antipsychotics. This risk was particularly high among users with schizophrenia or short-term use.

A significant proportion of individuals with serious mental illness who committed suicide by firearms were legally eligible to purchase and possess guns, according to recent findings.

Recent findings indicate that progress has been made regarding glucose testing among adults receiving antipsychotics, but lipid testing remains underutilized.

Prenatal exposure to nicotine was associated with increased risk for schizophrenia, according to recent findings.

The comorbidity of HIV and a serious mental illness such as bipolar disorder or schizophrenia presents multiple challenges for patients and clinicians. Risk factors for HIV acquisition, issues related to treatment engagement — including the choice of therapeutic regimens and medication adherence — and stigma associated with both conditions all complicate the treatment of this population.

ATLANTA — Henry Nasrallah, MD, of the department of neurology and psychiatry at St. Louis University, discusses the utility of the recently FDA-approved Nuplazid for psychosis in Parkinson’s disease.

ATLANTA — Data presented here indicated electroconvulsive therapy was effective for schizophrenia, but caused adverse cognitive effects in some patients.

ATLANTA — During the William C. Menninger memorial convocation lecture here, Thomas Frieden, MD, MPH, director of the CDC, reaffirmed the center’s commitment to mental health issues by highlighting the many examples of where public health and mental health intersect.

ATLANTA — Vraylar was generally safe, well-tolerated and effective in FDA-approved dose ranges among individuals with schizophrenia or bipolar I disorder, according to data presented at the American Psychiatric Association Annual Meeting.